pazopanib (votrient) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$28.2539 - $56.9742

VA Big4

$79.8913

VA FSS

$113.8264

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
pazopanib 400 mg (TABLET) $56.2746 AUS PBS generic
  • Votrient (60)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    pazopanib 400 mg (TABLET) $56.9742 AUS PBS generic
  • Votrient (30)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    pazopanib hydrochloride 200 mg (TABLET) $28.2539 AUS PBS generic
  • Votrient (90)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    pazopanib hydrochloride 200 mg (TABLET) $29.1867 AUS PBS generic
  • Votrient (30)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    pazopanib hydrochloride 200 mg (TABLET) $79.8913 VA Big4
  • VOTRIENT (120)
    		•  Novartis Pharmaceuticals Corporation
    pazopanib hydrochloride 200 mg (TABLET) $113.8264 VA FSS
  • VOTRIENT (120)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue